Publications by authors named "Roberto Conti"

Claim this Profile
B
Bilateral hip exoskeleton assistance enables faster walking in individuals with chronic stroke-related gait impairments.
Chiara Livolsi, Roberto Conti, Tommaso Ciapetti, Eleonora Guanziroli, Thor Fridriksson

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An impairment-specific hip exoskeleton assistance for gait training in subjects with acquired brain injury: a feasibility study.
Chiara Livolsi, Roberto Conti, Eleonora Guanziroli, Þór Friðriksson, Ásgeir Alexandersson

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making Bipedal Robot Experiments Reproducible and Comparable: The Eurobench Software Approach.
Anthony Remazeilles, Alfonso Dominguez, Pierre Barralon, Adriana Torres-Pardo, David Pinto, Roberto Conti

Front Robot AI· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robot-mediated overground gait training for transfemoral amputees with a powered bilateral hip orthosis: a pilot study.
Clara Beatriz Sanz-Morère, Elena Martini, Barbara Meoni, Gabriele Arnetoli, Antonella Giffone, Roberto Conti

J Neuroeng Rehabil· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance Evaluation of Lower Limb Exoskeletons: A Systematic Review.
David Pinto-Fernandez, Diego Torricelli, Maria Del Carmen Sanchez-Villamanan, Felix Aller, Katja Mombaur, Roberto Conti

IEEE Trans Neural Syst Rehabil Eng· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thermo-Catalytic Reforming of municipal solid waste.
Miloud Ouadi, Nils Jaeger, Charles Greenhalf, Joao Santos, Roberto Conti

Waste Manag· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photobioreactor cultivation and catalytic pyrolysis of the microalga Desmodesmus communis (Chlorophyceae) for hydrocarbons production by HZSM-5 zeolite cracking.
Roberto Conti, Laura Pezzolesi, Rossella Pistocchi, Cristian Torri, Patrizio Massoli

Bioresour Technol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bio-harvesting and pyrolysis of the microalgae Botryococcus braunii.
Khalid A Al-Hothaly, Eric M Adetutu, Mohamed Taha, Daniele Fabbri, Chiara Lorenzetti, Roberto Conti

Bioresour Technol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification.
Erminia Infusino, Alessandra Mameli, Roberto Conti, Diego Gaudino, Gerardina Stimato

Med Dosim· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivatives of R-aminocarnitine without ammonium moiety as liver carnitine palmitoyltransferase I (L-CPT I) inhibitors.
Emanuela Tassoni, Roberto Conti, Grazia Gallo, Silvia Vincenti, Lucilla Mastrofrancesco

ChemMedChem· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis.
Roberto Conti, Edoardo Mannucci, Pompeo Pessotto, Emanuela Tassoni, Paolo Carminati

Diabetes· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the increase in neuronal fatty acids availability on food intake and satiety in mice.
Roberto Coccurello, Antonio Caprioli, Sara Bellantuono, Francesca R D'Amato, Roberto Conti

Psychopharmacology (Berl)· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aminocarnitine ureidic derivatives as inhibitors of carnitine palmitoyltransferase I.
Emanuela Tassoni, Roberto Conti, Grazia Gallo, Silvia Vincenti, Natalina Dell'Uomo

ChemMedChem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice.
Roberto Coccurello, Daniela Brina, Antonio Caprioli, Roberto Conti, Orlando Ghirardi

J Clin Psychopharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyperphagia, and metabolic dysregulation in mice.
Roberto Coccurello, Antonio Caprioli, Roberto Conti, Orlando Ghirardi, Franco Borsini

J Pharmacol Exp Ther· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production.
Silvana Obici, Zhaohui Feng, Arduino Arduini, Roberto Conti, Luciano Rossetti

Nat Med· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity.
Fabio Giannessi, Pompeo Pessotto, Emanuela Tassoni, Piero Chiodi, Roberto Conti

J Med Chem· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis